GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Inc (NAS:IXHL) » Definitions » Float Percentage Of Total Shares Outstanding

Incannex Healthcare (Incannex Healthcare) Float Percentage Of Total Shares Outstanding : 99.31% (As of May. 28, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Incannex Healthcare Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Incannex Healthcare's float shares is 15.76 Mil. Incannex Healthcare's total shares outstanding is 15.87 Mil. Incannex Healthcare's float percentage of total shares outstanding is 99.31%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Incannex Healthcare's Insider Ownership is 21.54%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Incannex Healthcare's Institutional Ownership is 3.57%.


Incannex Healthcare Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Incannex Healthcare's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=15.76/15.87
=99.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incannex Healthcare (Incannex Healthcare) Business Description

Industry
Traded in Other Exchanges
N/A
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Incannex Healthcare (Incannex Healthcare) Headlines

From GuruFocus